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Longitudinal patterns of leukoaraiosis and brain
atrophy in symptomatic small vessel disease
Christian Lambert,1 Philip Benjamin,1,2 Eva Zeestraten,1 Andrew J. Lawrence,3
Thomas R. Barrick1 and Hugh S. Markus3
Cerebral small vessel disease is a common condition associated with lacunar stroke, cognitive impairment and signiﬁcant functional
morbidity. White matter hyperintensities and brain atrophy, seen on magnetic resonance imaging, are correlated with increasing
disease severity. However, how the two are related remains an open question. To better deﬁne the relationship between white
matter hyperintensity growth and brain atrophy, we applied a semi-automated magnetic resonance imaging segmentation analysis
pipeline to a 3-year longitudinal cohort of 99 subjects with symptomatic small vessel disease, who were followed-up for51 years.
Using a novel two-stage warping pipeline with tissue repair step, voxel-by-voxel rate of change maps were calculated for each
tissue class (grey matter, white matter, white matter hyperintensities and lacunes) for each individual. These maps capture both the
distribution of disease and spatial information showing local rates of growth and atrophy. These were analysed to answer three
primary questions: ﬁrst, is there a relationship between whole brain atrophy and magnetic resonance imaging markers of small
vessel disease (white matter hyperintensities or lacune volume)? Second, is there regional variation within the cerebral white matter
in the rate of white matter hyperintensity progression? Finally, are there regionally speciﬁc relationships between the rates of white
matter hyperintensity progression and cortical grey matter atrophy? We demonstrate that the rates of white matter hyperintensity
expansion and grey matter atrophy are strongly correlated (Pearson’s R = 0.69, P51  107), and signiﬁcant grey matter loss
and whole brain atrophy occurs annually (P5 0.05). Additionally, the rate of white matter hyperintensity growth was heteroge-
neous, occurring more rapidly within long association fasciculi. Using voxel-based quantiﬁcation (family-wise error corrected
P50.05), we show the rate of white matter hyperintensity progression is associated with increases in cortical grey matter atrophy
rates, in the medial-frontal, orbito-frontal, parietal and occipital regions. Conversely, increased rates of global grey matter atrophy
are signiﬁcantly associated with faster white matter hyperintensity growth in the frontal and parietal regions. Together, these
results link the progression of white matter hyperintensities with increasing rates of regional grey matter atrophy, and demonstrate
that grey matter atrophy is the major contributor to whole brain atrophy in symptomatic cerebral small vessel disease. These
measures provide novel insights into the longitudinal pathogenesis of small vessel disease, and imply that therapies aimed at
reducing progression of white matter hyperintensities via end-arteriole damage may protect against secondary brain atrophy
and consequent functional morbidity.
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Introduction
Cerebral small vessel disease is a group of heterogeneous
disorders that affect the small vessels of the brain (Pantoni,
2010). Small vessel disease is characterized by typical radio-
logical changes on MRI including white matter hyperinten-
sities (WMH), lacunar infarcts, cerebral microbleeds and
brain atrophy (Gouw et al., 2011), and is associated with
vascular risk factors, particularly hypertension (Jeerakathil
et al., 2004). Small vessel disease is a highly prevalent dis-
ease that increases with age (De Leeuw et al., 2001), and is
part of a clinical spectrum that ranges from asymptomatic
disease detected on brain imaging in healthy adults through
to extensive WMH and lacunar infarct in vascular demen-
tia (Pantoni, 2010; Patel and Markus, 2011).
WMHs, best observed on T2-weighted magnetic reson-
ance images, are one of the conventional MRI markers of
small vessel disease (Gouw et al., 2011). However, ex vivo
correlates of these high signal regions reveal a spectrum of
pathophysiological processes including white matter demye-
lination and rarefaction through to axonal loss and gliosis
(Braffman et al., 1988; Munoz et al., 1993; Gouw et al.,
2011). Many of these changes are thought to have an is-
chaemic pathogenesis (Fernando et al., 2006). The arterial
supply to deep white matter regions is via long penetrating
arteries that originate at the pial surface, and then travel up
to 5 cm with myelinated axons to irrigate deep white matter
structures (Pantoni and Garcia, 1997). These end arterial
regions form watershed areas that are particularly prone to
ischaemic damage in response to changes in cerebral blood
ﬂow. Functionally, the rate of WMH progression is asso-
ciated with decline in verbal IQ (Garde et al., 2005) and
executive function (Debette and Markus, 2010), and is a
predictor of future stroke (Yamauchi et al., 2002) and non-
Alzheimer’s dementia (Steffens et al., 2007) risk.
Consequently, WMH volume has also been proposed as a
clinically relevant disease marker that can be pharmaco-
logically modulated, and has been proposed as an end
point in clinical trials (Dufouil et al., 2005).
Previous studies have demonstrated that increasing small
vessel disease is associated with increases in both WMH
volume and brain atrophy (Godin et al., 2009; Nitkunan
et al., 2011; Patel and Markus, 2011). In particular, the
brain atrophy predominantly affects the cortical grey
matter (Du et al., 2005) and has been shown to correlate
with cognitive impairment (Nitkunan et al, 2011; Jokinen et
al., 2012) and gait decline (de Laat et al., 2012). However,
whether the observed vascular lesions independently cause
secondary brain atrophy, and if so how this process is
mediated, remain open questions (Appelman et al., 2009;
Wardlaw et al., 2013). Several possibilities have been pro-
posed: it maybe that the brain atrophy is due to white
matter damage leading either to subsequent downstream de-
nervation (O’Sullivan et al., 2001), or a result of volumetric
loss of white matter constituents such as myelin, axons, and
oligodendrocytes (Appelman et al., 2009). Alternatively, in-
trinsic cortical disease due to processes such as cortical
microinfarcts (Smith et al., 2012) may cause cortical grey
matter atrophy. Furthermore data on regional variation in
the longitudinal rates of atrophy related to rate of WMH
progression are lacking, casting uncertainty on the nature
and direction of the association between WMH and brain
atrophy (Appelman et al., 2009). If a ‘disconnection
phenomenon’ due to white matter denervation does play a
role in brain atrophy, one might expect a relationship be-
tween the rates of WMH progression and regional cortical
grey matter atrophy. In addition, white matter lesions are
known to be spatially heterogenous (Artero et al., 2004;
DeCarli et al., 2005), progressing at different rates in differ-
ent cortical locations. Precise mapping of the longitudinal
rate of WMH growth would be expected to provide further
clues into the underlying pathophysiological process.
To better deﬁne the relationship between WMH growth
and brain atrophy we developed a 3D spatial model of
WMH progression in cerebral small vessel disease, and
generated WMH rate maps to show the rate of WMH ex-
pansion within each voxel. We used these to characterize
the spatial progression of small vessel disease WMH in a
prospective longitudinal cohort of individuals with symp-
tomatic small vessel disease (deﬁned as having suffered
a prior clinical lacunar syndrome), and determine its asso-
ciation with brain atrophy using whole brain, semi-
automated, morphometric techniques. First, we aimed to
demonstrate the relationship between the rates of WMH
growth and brain atrophy. Secondly, previous studies
using region of interest based analysis have shown that
the rate of WMH accumulation is non-uniform and more
rapid in the fronto-parietal regions. Using the 3D voxel-
by-voxel rate maps we deﬁne the characteristic pattern of
WMH accumulation, and use statistical analysis to identify
regions of WMH growth that are correlated with the rate
of brain atrophy.
Materials and methods
Subjects
Patients in the SCANS (St George’s Cognition and
Neuroimaging in Stroke) cohort were studied. This prospective
longitudinal study recruited 121 subjects with symptomatic
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small vessel disease and followed them up longitudinally.
Recruitment was from acute stroke units or outpatient stroke
clinics in three hospitals covering a contiguous catchment area
in South London (St George’s, King’s College and St Thomas’
Hospitals). Inclusion criteria comprised a clinical lacunar syn-
drome (Bamford et al., 1987) with an anatomically corres-
ponding lacunar infarct in addition to evidence of conﬂuent
leukoaraiosis (modiﬁed Fazekas grade5 2; Fazekas et al.,
1993; Hassan et al., 2003) on MRI. Exclusion criteria
were: any cause of stroke mechanism other than small vessel
disease, other major CNS disorders, major psychiatric dis-
orders, any other cause of white matter disease, contraindica-
tions to MRI, or non-ﬂuent in English. Patients were studied at
least 3 months after their last stroke. All subjects provided
written consent, and the study was approved by the local
ethics committee.
Subjects were invited annually for repeated cognitive testing
and MRI scanning. Recruitment began in December 2007 and
ended in August 2010. MRI scanning began in January 2008
and was completed in October 2013. In this analysis follow-up
data to 3 years were used, providing a maximum of four
datasets per individual. Of these, 99 subjects returned at one
or more time-points: 98 at Year 1, 77 at Year 2 and 71 at
Year 3. One subject attended the baseline and missed the Year
1 follow-up, but attended all subsequent sessions. Four sub-
jects missed the Year 2 follow-up, but subsequently attended at
Year 3. These are summarized with the reasons for dropout in
Fig. 1, and a detailed breakdown of the demographics is pro-
vided in Table 1. Additionally, over the period reported there
were three new clinical strokes, two lacunar and one cortical
haemorrhage. Intercerebral haemorrhage was a predeﬁned
end-point and the patient was withdrawn from the study.
The two lacunar stroke cases were allowed to remain in the
study, as stated in the protocol, although one subsequently
withdrew due to disability. All available longitudinal data
(n = 99) were used for analysis.
Image acquisition
All magnetic resonance images were acquired using the Signa
HD 1.5 T Magnetic Resonance Scanner (General Electric) at St
George’s, University of London. The maximum gradient amp-
litude was 33 mTm1 and a proprietary 8-channel head coil
was used. All subjects were placed in the head coil and an
alignment marker was used at the nasal bridge. Velcro straps
and foam pads were used where possible to minimize head
movement. Whole brain T1-weighted and ﬂuid-attenuated in-
version recovery (FLAIR) images were acquired for each sub-
ject using the following protocol: (i) FLAIR sequence:
repetition time/echo time/inversion time = 9000/130/2200ms,
ﬁeld of view = 240  240mm2, matrix = 256  192, 28
axial slices of 5-mm thickness providing a ﬁnal image
Figure 1 Longitudinal cohort flow chart. Flow chart
demonstrating the changes in annual cohorts and reasons for sub-
ject dropout at each time point. Dashed lines: one subject attended
the baseline, missed the Year 1 scan but attended Year 2 onwards.
Four subjects missed their Year 2 follow-up but attended all other
time points (baseline, Years 1 and 3).
Table 1 Summary of cohort demographics at each time point
Time point
Baseline Year 1 Year 2 Year 3 Average
n 99 98 77 71 -
Age at time point (years) 68.9 (9.98) 69.97 (10.14) 70.71 (9.24) 71.71 (9.24) 70.17 (9.70)
Female 33 (33%) 33 (34%) 26 (34%) 26 (37%) 30 (34%)
Male 66 (67%) 65 (66%) 51 (66%) 45 (63%) 57 (66%)
Hypertension 92 (93%) 91 (93%) 71 (92%) 66 (93%) 80 (93%)
Hypercholesterolaemia 85 (86%) 84 (86%) 65 (84%) 62 (87%) 74 (86%)
Current smoker 21 (21%) 21 (21%) 16 (21%) 15 (21%) 18 (21%)
Ex-smoker 34 (34%) 33 (34%) 25 (33%) 22 (31%) 29 (33%)
Diabetes 19 (19%) 19 (19%) 18 (23%) 17 (24%) 18 (21%)
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resolution of 0.47  0.47  5mm; and (ii) spoiled gradient echo
recalled T1-weighted (SPGR) 3D coronal sequence: repetition
time/echo time = 11.5/5ms, ﬁeld of view = 240  240mm2,
matrix = 256  192, ﬂip angle = 18, 176 coronal slices of
1.1-mm thickness providing a ﬁnal image isotropic resolution
of 1.1mm.
Preprocessing
Initially the raw DICOMs were imported using Statistical
Parametric Mapping 8 (SPM8) software (http://www.ﬁl.ion.
ucl.ac.uk/spm/software/spm8/), and each image checked to
ensure a common orientation. The T1-weighted and FLAIR
images were aligned using an afﬁne co-registration in SPM
for each individual, before being co-registered to MNI orien-
tation and reslicing to 1mm isotropic voxel resolution in sub-
ject space using fourth degree b-spline interpolation.
Definitions
The longitudinal pipeline involved working principally in four
separate image spaces and exploited a two step-warping pro-
cedure to characterize the temporal changes. For reference, the
main terminology and space deﬁnitions have been provided in
Supplementary Fig. 1.
Segmentation
The segmentation steps were adapted and optimized to our
study population as described in Lambert et al. (2015), but
are fully summarized below for reference. In essence, the
adapted segmentation pipeline consisted of four steps. First,
a group average template was created and the T1-weighted
and FLAIR images were warped to this space. Second, the
warped T1-weighted and FLAIR images were used to create
population-speciﬁc tissue probability maps (TPMs). Third,
the new TPMs were used to resegment the native images
creating grey matter, white matter, CSF and WMH tissue
classes. These were then combined with the manually deﬁned
lacune regions of interest, resulting in ﬁve tissue classes per
individual. Finally, a tissue repair step was performed to gen-
erate repaired grey matter, white matter and CSF maps for
each individual dataset. Description of the subsequent longi-
tudinal warping procedure that uses all the segmented tissue
maps will be detailed separately after the segmentation steps.
Figure 2 summarizes the principle segmentation steps (two
and three detailed above) and the subsequent longitudinal
two stage warping procedure. Technical details for the gen-
eration of population-speciﬁc TPMs may be found in
Lambert et al., (2013). Additional details for each step have
been provided in the Supplementary material. For clarity,
SPM8 New Segment was used to develop and apply the seg-
mentation pipeline (as this version was available during initial
methodological development) but with customized TPMs gen-
erated from our data rather than default SPM TPMs. SPM12
was available for our later analysis and was used for all sub-
sequent longitudinal warping (via the new ‘Shoot’ toolbox)
and statistical analysis.
Step 1: Create initial group average space
Initially the native space T1-weighted images were segmented
into grey matter, white matter and CSF tissue classes using the
uniﬁed segmentation (‘New Segment’) within SPM8
(Ashburner and Friston, 2005). These segmentations were
registered to a common group-average 1mm isotropic voxel
template image using a diffeomorphic registration algorithm
(Ashburner and Friston, 2011), and the T1-weighted and
FLAIR images warped to this space. These images were
skull-stripped using the warped segmentations at a tissue prob-
ability threshold of 0.1, and manually checked and corrected
where necessary.
Step 2: Create population-specific tissue
probability maps
Population-speciﬁc TPMs were created for three tissue classes
(grey matter, white matter and CSF) using the warped, skull-
stripped T1-weighted images and a Modiﬁed Mixture of
Gaussians algorithm to account for anatomical features spe-
ciﬁc to the study cohort, such as larger ventricles. Using the
warped skull-stripped FLAIR and T1-weighted images, TPMs
were generated for the WMHs using a Modiﬁed Multivariate
Mixture of Gaussians (Lambert et al., 2013). These TPMs then
replaced the default maps supplied by SPM in the New
Segment pipeline.
Step 3: Re-segmenting the native space images
The new TPMs were used to resegment the native space struc-
tural images into grey matter, white matter, CSF and WMH.
The central corpus callosum and fornix were excluded from
the WMH segmentation by masking with a group average
mask. This was performed to reduce the regional variation
of voxel intensities in these structures that cause frequent
tissue misclassiﬁcation. The WMH segmentations were binar-
ized at a manually determined threshold for each individual.
This threshold was determined by overlaying the segmenta-
tions onto the corresponding FLAIR images using ITK-SNAP
version 2.2.0 (www.itksnap.org) (Yushkevich et al., 2006), to
ensure each individual WMH map accurately deﬁned the spa-
tial extent of the lesions. This step was performed independ-
ently by two raters (C.L. and E.Z.), and inter- and intra-rater
reliability metrics checked using 10 randomly selected scans
across all time points, duplicated to provide a total set of 20
scans per rater, each set randomly reordered for each rater to
avoid any sequence bias. Both raters were blinded with respect
to subject and time-point of each scan. Each binary map was
further checked and corrected where necessary using ITK-
SNAP. The WMH manual reﬁnement removed areas of mis-
segmentation that were apparent in some areas with similar
voxel intensity proﬁles to WMHs, and was most often
required in the hippocampus and posterior insula. This step
did not alter the contours or extent of the automatically deli-
neated WMH lesions. Areas of lacunar infarction were manu-
ally identiﬁed on native space T1-weighted images using
published criteria (Benjamin et al., 2014). This was aided by
overlaying CSF segmentations on corresponding FLAIR images
to identify regions of misclassiﬁcation. Regions were seg-
mented using a space-ﬁlling algorithm in ITK-SNAP, using
voxel intensity thresholds (set to between 350 and 500) with
500 iterations. These results were visually checked and
manually reﬁned where necessary. This step was performed
independently by two raters (C.L. and P.B.), and inter- and
intra-rater reliability checked using 20 randomly selected
scans across all time points, as detailed above. Again
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Figure 2 Summary of the longitudinal preprocessing pipeline. The tissue repair step is outlined in the methods and detailed further in
Lambert et al. (2015). GM = grey matter; WM = white matter; LI = lacunar infarct.
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the raters were blinded to the subject and time-point of each
scan.
Step 4: Tissue repair
One of the problems associated with segmenting brains with
WMH and lacunar infarct is that regions of damage can be
misclassiﬁed into erroneous tissue types due to changing tissue
intensity proﬁles as a result of pathology. Regions of WMH
are often classed as grey matter, and gliosis within lacunar
infarct as CSF, in a standard segmentation result from
SPM8. This misclassiﬁcation will cause inaccuracies when
warping the segmentations together to a group average tem-
plate, and impair the ability to accurately map areas of
damage to a common space. For example, a region of gliosis
caused by a lacune in the head of the caudate would be
warped with the CSF tissue class into the adjacent lateral ven-
tricle. To overcome this limitation a segmentation repair step
was undertaken. The WMH binary maps were used to identify
brain regions that should be classed as white matter. These
regions were subsequently corrected in the corresponding
white and grey matter segmentations, by zeroing the WMH
regions in grey matter, and adding them to white matter. As
lacunar infarct may cross tissue boundaries they were mapped
to the initial group average space and the TPMs were used to
deﬁne the most likely tissue class in the lacunar infarct regions
over all time-points. This was then used to reclassify the native
grey matter, white matter and CSF maps.
To further improve the segmentations, each baseline T1-
weighted image was processed using the recon-all pipeline in
Freesurfer (version 5.0; Fischl et al., 2002). The resultant par-
cellation image was binarized and combined with the repaired
segmentations to create an individual brain mask. Each mask
was then manually checked in ITK-SNAP to remove any erro-
neously classiﬁed brain voxels around the margins of the skull
and dura. Copies of individual baseline brain masks were then
co-registered using SPM12 to all future time points using the
corresponding T1-weighted images. The ﬁnal brain mask for
each time point was then used to remove any erroneously
classiﬁed grey and white matter voxels in the segmentations
and these were included in the CSF images. At each time point,
the ﬁnal result was visualized and, if necessary, the masks were
further reﬁned manually.
For each scan, the unrepaired segmentations were used to
calculate tissue volumes. The WMH, lacunar infarct, total
cerebral volume (deﬁned as the sum of grey matter, white
matter and WMH at a tissue probability threshold50.2)
and total intracranial volume (deﬁned as total cerebral
volume plus the CSF volume at a set tissue probability thresh-
old50.2, constrained by the ﬁnal brain inclusion mask) were
calculated in mm3.
Reliability metrics were calculated as per Dunn et al. (2013).
The inter-rater reliability metrics were calculated using the
mean values for each rater. Good measures of reliability
were obtained for the MRI measures that needed manual re-
ﬁnement. For WMHs, the inter-rater reliability metrics were:
standard error of mean (SEM) = 247mm3, mean variabil-
ity = 7.78% [standard deviation (SD) = 3.03%], Pearson’s
intra-class correlation coefﬁcient = 0.98. The intra-rater reli-
ability metrics were: SEM = 187mm3, mean variabil-
ity = 5.57% (SD = 3.99%), Pearson’s intraclass correlation
coefﬁcient = 0.99. For lacunar infarct, the inter-rater reliability
metrics were: SEM = 3mm3, mean variability = 7.93%
(SD = 4.89%), Pearson’s intra-class correlation coefﬁ-
cient = 0.99. The corresponding intra-rater reliability metrics
were: SEM = 2mm3, mean variability = 4.32% (SD = 4.19%),
Pearson’s intraclass correlation coefﬁcient = 0.99. There were
no signiﬁcant differences between the volumes measured by the
two raters.
Longitudinal warping pipeline
To calculate longitudinal volumetric changes in small vessel
disease and to enable statistical analysis regardless of the
number of time points, we developed a two-stage warping
pipeline by adapting the available SPM framework (Fig. 2)
that ﬁrst warped each subject to an individual average tem-
plate that represents the average mid-point brain. This step
provides a voxel-wise trajectory, based on the non-linear de-
formations to the average individual brain, for each time point.
These are expressed as divergence maps (for each time point)
in SPM as detailed below. To create a ‘rate map’ we performed
a voxel-wise linear ﬁt between the divergence maps, using the
time between scans as the basis (Ashburner and Ridgway,
2012). These individual rate maps show the relative speed of
tissue expansion or contraction for every voxel in the brain per
year and were used for analysis.
Step 1: Individual average space
Initially for each individual, the ﬁve tissue type maps (grey
matter, white matter, CSF, WMH and lacunar infarct), and
all available time points (between two and four per subject)
were warped to an individual average template using the
Shoot toolbox in SPM12. This produced Jacobian determin-
ant, warp and velocity ﬁelds for each time-point in addition
to the individual average tissue template images. The velocity
ﬁelds were used to calculate divergence maps using the in-
built SPM12 function spm_shoot_divergence. For each voxel,
the divergence maps quantify the diffeomorphic distance
between the subject time point image from the average
image, and represent the amount of expansion or contraction
required to warp it to the average image. For each voxel,
across all divergence maps for an individual, a linear ﬁt
was calculated with respect to the time between scans to gen-
erate a single ‘rate map’ for each subject. These steps were
then repeated using the three repaired tissue classes to pro-
duce a repaired individual average image and a rate map for
each corrected tissue type.
Step 2: Group average space
Individual repaired average tissue class templates were gener-
ated by the longitudinal warping in Step 1. In Step 2, the three
average tissue classes for each individual were used in the
Shoot pipeline to provide deformations to a group average
space.
Longitudinal analysis
For each subject, the following images from individual average
space were warped to the group average template: grey matter
template, white matter template, WMH template, lesion rate
maps and repaired rate maps. Each of the warped tissue classes
was multiplied by the warped rate maps (WMH by lesioned-
rate images, grey matter and white matter by repaired-rate
images). These unsmoothed images were used to produce the
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group average rate images for each tissue class, reﬂecting the
average expansion and atrophy across the whole brain in the
entire cohort. Because the distribution of WMH was variable
over the cohort, a normalized average WMH rate map was
also calculated by dividing the sum of all the warped WMH
rates by the sum of all warped binarized WMH maps i.e. for
each voxel only data from individuals where a speciﬁc voxel
contains a lesion, rather than over the entire group, were used
to generate an average for that point.
To statistically analyse the tissue-speciﬁc rate maps, a voxel-
based quantiﬁcation approach was adopted (Draganski et al.,
2011). Speciﬁcally the rate maps for WMH and repaired grey
matter were treated as parameter maps, and the combined
weighting/smoothing procedure described in Draganski et al.
(2011) used to produce warp-weighted average images. These
avoid the parameter value changes caused by the necessary
Gaussian smoothing in standardized space and have previously
been used in a similar fashion for cortical thickness parameter
maps (Hutton et al., 2009). In this work, the grey matter and
WMH warp-weighted average rate maps were smoothed using
a 6mm full-width at half-maximum Gaussian kernel.
Whole brain volumetric MRI
parameters
Total cerebral volume, grey matter, white matter, lacunar in-
farct, and WMH volumes were calculated for each individual
and used to calculate percentage change from baseline and
annualized rate of volumetric change. For each MRI parameter
annualized rate of change was calculated from all available
time points (e.g. time in years from baseline) using a least
squares linear ﬁt in MATLAB 2013a. These were calculated
both using each time point cohort (i.e. only taking data from
baseline to the corresponding time-point) to assess how these
measures changed as the cohort declined due to dropout, and
also using the entire population over all available time points
to generate a single summative measure.
Statistical data analysis
All analyses were performed in MATLAB 2013a unless speci-
ﬁed, and the data were grouped either according to time-point
or outcome as speciﬁed. Tests between time points used a one-
tailed test given the a priori expectation that brain volumes
decline and lesioned tissue increases with time, whereas all
other t-tests were two-tailed. Data distributions were assessed
using histograms. The normally distributed data were explored
initially using an ANOVA, and if signiﬁcant a two-sample t-
test was used to examine differences between groups. Non-
parametric data were tested using a Kruskal-Wallis test.
Pearson’s correlation was used to calculate correlation coefﬁ-
cients (r). Results signiﬁcant at P50.05 were reported.
Statistical image analysis
All analysis was performed in SPM12. All group analyses were
performed in the population optimized group average space.
The objective was to identify regions where the rate of grey
matter atrophy and WMH growth were signiﬁcantly correlated
with one another. To achieve this, the warp-weighted average
rate maps (grey matter and WMH) were analysed using
multiple regression models in SPM. The dependent variables
were the average whole brain rate values (as speciﬁed in the
‘Whole brain volumetric MRI parameters’ section) for either
grey matter or WMH. Confounding variables were baseline
age, lacunar infarct volume, total intracranial volume and
gender. In models using the grey matter rate maps, the baseline
WMH volumes were also included as a confounding covariate.
The ﬁrst multiple regression model tested the grey matter
rate maps for positive and negative correlations with average
WMH rate and age (four statistical tests total). In the second,
the WMH rate maps were tested for positive and negative
correlations with average grey matter rate and age (four stat-
istical tests total).
In all statistical analyses the regions that survived family-
wise error (FWE) multiple comparison correction at P50.05
were considered signiﬁcant. All signiﬁcant results are displayed
at both P5 0.001 uncorrected and FWE corrected P50.05
and the legend labelled accordingly. All images are shown
using the neurological convention.
Results
Demographics
A total of 99 subjects had more than one time point, and
were included in the analysis as outlined in the ‘Materials
and methods’ section. The physical longitudinal demo-
graphics including vascular risk factors are shown in
Table 1. Functional baseline averaged measures include:
Rankin (1.1  1.0), Mini-Mental State Examination
(27.9  2.4) and National Adult Reading Test IQ
(99.8  15.4). A detailed breakdown of baseline character-
istics of this cohort have been described in detail elsewhere
(Lawrence et al., 2013).
MRI measures
Overall
The changes in MRI parameters are summarized in Table 2
and Supplementary Fig. 2. The average total cerebral
volume over all available time points was 1020  103
mm3 (SD = 100  103 mm3, range 740–1240  103 mm3),
and average volumes of the composite compartments were
649  103 mm3 for grey matter (SD = 66  103 mm3,
range 502–779  103 mm3) and 322  103 mm3 for
white matter (SD = 59  103 mm3, range 163–471  103
mm3). The median WMH volume was 44.1  103 mm3
(SD = 29.3  103 mm3, range 3.5–150.2  103 mm3). At
baseline, WMH volume did not correlate with age
(Pearson’s coefﬁcient, r = 0.07, P = 0.47) or total brain
volume (Pearson’s coefﬁcient, r = 0.13, P = 0.14).
Longitudinal
These are summarized in Table 2 and Supplementary Fig.
2. There was a progressive decline in total cerebral volume,
grey matter and white matter over time with annualized
rates of159  103 mm3/year,149.6  103 mm3/year
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and88  103 mm3/year, respectively. There was a signiﬁ-
cant difference grey matter and total cerebral volume be-
tween baseline and Years 1, 2, and 3 (P50.005 for grey
matter, P5 0.05 for total cerebral volume), and between
the baseline and ﬁnal white matter volumes (P5 0.05),
which may indicate that the progressive loss in total cere-
bral volume is being largely contributed by grey matter
changes. The rate of total cerebral volume and grey
matter decline was reduced signiﬁcantly in the Year 1
and Year 2 cohorts (P5 1  104). We found no correl-
ations between the rates of grey matter, white matter and
total cerebral volume change compared to their respective
baseline volumes.
In contrast, the overall volume of WMH increased progres-
sively each year. The median annualized WMH growth rate
was 5.6  103 mm3/year (SD = 8.1  103 mm3, range 0.82–
65.9  103 mm3/year). There was a signiﬁcant positive cor-
relation between total baseline WMH volume and the
annualized rate of WMH growth (Pearson’s R = 0.49,
P5 1  104). Examining the separate tissue types, the
rate of WMH expansion was strongly correlated with rate
of grey matter atrophy (Pearson’s R = 0.69, P5 1  107)
and weakly correlated with white matter (Pearson’s
R = 0.26, P = 0.01). Additionally, the median annualized
rates (mm3/year) for WMH and lacunar infarct were strongly
positively correlated (Pearson’s R = 0.59, P5 1  107).
Finally the median rate of total lacunar infarct volume
increase remained reasonably static over all time points
(30mm3/year). This parameter was moderately negatively
correlated with grey matter (Pearson’s R = 0.34,
P5 0.005), but not white matter or total cerebral volume.
Average whole brain white matter
hyperintensity changes
Figure 3 shows the group average distribution of WMH,
and normalized WMH rate. The normalized map repre-
sents the average rate of growth in subjects where a lesion
is located in a particular voxel, whereas the WMH distri-
bution map provides complementary information regard-
ing the actual probability of a lesion being present in a
speciﬁc voxel across the population. Overall the rate of
WMH growth was greater in the gyral white matter close
to the cortical mantle, at the edge of the WMH
Table 2 Summary of MRI parameters at each time point
Time point
Baseline Year 1 Year 2 Year 3 Overall
n 99 98 77 71 -
Demographics and risk factors
Age at time point (years) 68.90 (9.98) 69.97 (10.14) 70.71 (9.24) 71.71 (9.24) 70.17 (9.70)
Female (n) 33 (33%) 33 (34%) 26 (34%) 26 (37%) -
Male (n) 66 (67%) 65 (66%) 51 (66%) 45 (63%) -
Hypertension (n) 92 (93%) 91 (93%) 71 (92%) 66 (93%) -
Hypercholesterolaemia (n) 85 (86%) 84 (86%) 65 (84%) 62 (87%) -
Current smoker (n) 21 (21%) 21 (21%) 16 (21%) 15 (21%) -
Ex-smoker (n) 34 (34%) 33 (34%) 25 (32%) 22 (31%) -
Diabetes (n) 19 (19%) 19 (19%) 18 (23%) 17 (24%) -
Volume measurements
Mean grey matter (mm3) 669 596 (65 898) 643 210 (64 077) 640 944 (63 226) 635 230 (64 979) 648 634 (65 745)
Mean white matter (mm3) 331 400 (59 000) 323 568 (56 882) 321 063 (55 211) 311 455 (63 210) 322 763 (58 645)
Mean total cerebral
volume (mm3)
1 038 030 (104 134) 1 012 586 (101 527) 1 008 459 (98 714) 995 645 (110 147) 1 015 480 (104 204)
Median WMH (mm3) 31 899 (26 640) 37 604 (31 215) 39 071 (29 606) 43 338 (28 400) 44 080 (29 257)
Median lacune (mm3) 251 (713) 317 (799) 317 (844) 377 (882) 317 (802)
Percentage change from baseline (%)
Mean total grey matter - 3.83 (2.00) 4.45 (1.81) 5.27 (1.88) 4.44 (1.99)
Mean total white matter - 2.21 (3.93) 4.50 (4.80) 7.86 (6.55) 4.56 (5.56)
Mean total brain - 2.39 (1.16) 3.09 (1.54) 4.19 (2.27) 3.13 (1.81)
Median total WMH - + 24.40 (25.26) + 46.17 (34.20) + 59.55 (54.45) + 38.50 (42.88)
Median lacune - + 13.43 (21.97) + 22.22 (24.60) + 29.92 (23.15) + 27.75 (27.05)
Annualized fitted rates (mm3/year)
Mean grey matter - 25 647 (13 692) 14 949 (6314) 11 021 (4089) 14 860 (10 866)
Mean white matter - 7845 (12 973) 7591 (7390) 8506 (6781) 8838 (7340)
Mean total cerebral volume - 24 958 (12 234) 16 080 (7816) 13 670 (7525) 15 873 (9997)
Median WMH - + 5860 (9043) + 5385 (4502) + 5127 (3880) + 5626 (8095)
Median lacune - + 37 (129) + 30 (75) + 29 (75) + 30 (89)
SD is shown in brackets unless otherwise stated.
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distributions in regions of low probability WMH lesions.
This is to be expected, as the WMH lesion edges in sub-
jects with severe, conﬂuent high volume disease would be
located in these gyral regions, and is consistent with the
earlier observed positive correlation between WMH
volume and WMH growth rate. This effect was most ap-
parent in the fronto-parieto-occipital regions. However,
there was also heterogeneity in the rate of WMH
growth in the deeper non-gyral white matter. While this
was highest in the region of the corticospinal tract and
parietal centrum semiovale, regions of faster growth
were observed to conform to major white matter fasciculi
when compared against a white matter atlas
(Schmahmann and Pandya, 2009). These are annotated
in Fig. 3, and include the superior longitudinal fasciculus,
fronto-occipital fasciculus, arcuate fasciculus, inferior lon-
gitudinal fasciculus, forceps major and minor and the stri-
atal bundle. This indicates that development of WMH
changes occur more rapidly within major white matter
fasciculi, particularly long association white matter bun-
dles. This observation crosses vascular boundaries (Fig. 3)
and is therefore not associated with larger arterial changes
or cortical microinfarcts but instead the end arteriole
supply. If the former were responsible, the spatial pattern
of WMH rate would be expected to show acceleration
along the supplying perforators.
Grey matter rate maps
Regions of the grey matter volumetric rate of change maps
that were signiﬁcantly negatively correlated with WMH
growth rate while controlling for baseline age, gender,
baseline WMH volume, lacunar infarct volume and total
intracranial volume are shown in Fig. 4. There was no
signiﬁcant positive correlation between grey matter and
WMH rates, and there was no signiﬁcant association be-
tween grey matter rates and age in our cohort. Signiﬁcant
results show increased rates of grey matter atrophy related
to increasing WMH growth in the occipital lobe, superior
parietal lobe (including the precuneus), prefrontal and orbi-
tofrontal regions, in addition to the striatum. Additionally,
there were symmetrical changes observed in the cerebellum
and dentate nuclei. There was notable sparing of the medial
temporal lobe and hippocampus.
Figure 3 Group average WMH rate maps. Axial projections of group average WMH rate maps shown using the neurological convention.
Top row shows overall average over the group, bottom row has been normalized by averaging across individual subject voxels only where WMH is
present and represents the average rate if WMH is found in a particular voxel. Bottom images display two coronal sections with annotation of the
corresponding white matter anatomy according to Schmahmann’s white matter atlas (Schmahmann and Pandya, 2009).
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White matter hyperintensity rate
maps
Regions of the WMH rate maps that were signiﬁcantly
negatively correlated with grey matter rate of change
whilst controlling for baseline age, gender, baseline lacunar
infarct volume and total intracranial volume are shown in
Fig. 5. There was no signiﬁcant positive correlation, and
there was no signiﬁcant association between WMH growth
rate with age in our cohort. Signiﬁcant results show that
regions where the rate of WMH expansion was most sig-
niﬁcantly correlated with increasing grey matter atrophy
were in the parietal/precuneus region around the centrum
semiovale, in the occipital lobe in the optic radiations and
forceps major, and frontally adjacent to the forceps minor.
Dropout cohort
Because of signiﬁcant changes in the measured volumes
compared to the baseline but non-signiﬁcant changes be-
tween the later time points, a subanalysis was performed
to examine whether the characteristics of the subjects who
withdrew from the study could account for this. The results
of this analysis are summarized in Table 3. To note, the
apparent differences in the demographic and risk factor
columns between Tables 1 and 3 are caused by ﬁve subjects
who missed a time point before reattending (as shown in
Fig. 1). This slightly modiﬁes the cross-sectional results
shown in Table 3, which summarizes results obtained for
all subjects who continue in the study, versus those who
dropout. Dropouts had signiﬁcantly higher burdens of
small vessel disease as reﬂected by WMH volume at both
time points. Furthermore, the annualized rate of expansion
for WMH was signiﬁcantly higher in drop-outs for these
variables at both time points compared to participants who
continued in the study. The differences between median
WMH volumes and annualized WMH rate between the
Year 1 and 2 dropout groups were not signiﬁcant. The
reasons for subject dropout are provided in
Supplementary Table 1.
Discussion
This study has characterized the longitudinal progression of
WMH in symptomatic cerebral small vessel disease. We
have shown changes in normal and lesioned tissue subtypes
both in terms of absolute volumes and ﬁtted rates, and
demonstrated an association particularly between the grey
matter and WMH volumes and rates of change. Our results
suggest that WMH growth is linked to the underlying
white matter anatomy of the long association fasciculi.
Furthermore, we have shown that the rate of WMH
growth is strongly correlated with regional grey matter at-
rophy, and that grey matter atrophy contributes most to
the secondary reductions in global brain volume that have
been previously observed. The results also suggest a
phenotypic speciﬁc pattern in the rate of grey matter loss
associated with small vessel disease severity that is charac-
terized by increasing fronto-parieto-occipital atrophy with
notable sparing of the medial temporal lobe and hippocam-
pus. Taken together, these observations suggest that the
rate of WMH growth is due to disruption of the end ar-
terial supply from the long perforators as opposed to more
proximal occlusion, and that this damage is related to re-
gional cortical atrophy through secondary downstream de-
nervation (‘disconnection phenomenon’).
Longitudinal white matter hyperin-
tensity progression
The MRI appearance of WMH lesions can arise from a
diverse range of pathological events (Pantoni and Garcia,
1997). In cerebral small vessel disease, myelin rarefaction
with axonal destruction is found particularly in the more
diffuse centrum semiovale lesions (Revesz et al., 1989) that
are associated with hyalinization of the long perforating
arterioles impairing the axonal vascular supply (Erten-
Lyons et al., 2013) and upregulation of endothelial hypoxic
markers (Fernando et al., 2006). These form watershed
zones where the white matter is particularly vulnerable to
damage (DeCarli et al., 2005). In our study, the uniform
high frequency of observed WMH occurrence within the
deep non-gyral white matter that crosses vascular territories
would be consistent with this proposed long perforator
pathology. It has been suggested that cortical microinfarcts
may also contribute to WMH formation (Smith et al.,
2012). However, this current work demonstrates structured
heterogeneity in the rate of progression WMH lesions that
aligns with underlying myeloarchitecture (Fig. 3). We have
demonstrated that WMH progress more rapidly when
located within regions of long association fasciculi com-
pared to other white matter regions; however, once lesions
are present within these structures they progress at a rela-
tively uniform rate. This suggests that there is underlying
variation in the axonal vulnerability to ischaemic damage.
The observation of a highly structured yet uniform pattern
would be extremely unlikely if a more randomly distributed
process, such as focal cortical micro-infarcts or subcortical
lacunes (Supplementary Fig. 3), were contributing signiﬁ-
cantly to the rate of WMH formation, or alternatively if
WMH expanded uniformly from the distal edge of pre-
existing lesions. These long fascicles are generally densely
packed and highly myelinated (Curnes et al., 1988) and
critically dependent on a continuous supply of oxygen
and glucose mediated by astrocytes (Pantoni et al., 1996;
Wender et al., 2000; Cambron et al., 2012) to support their
metabolic demand. The observed vulnerability may emerge
through a combination of their remote location from cor-
tical mantle, with subsequent dependence on end arterial
supply from the long perforators, which are prone to vas-
cular damage and hyalinization, combined with a higher
metabolic demand due to the intrinsic myeloarchitectural
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properties within the fascicles. This two-hit hypothesis
would also account for the temporal fascicles (inferior lon-
gitudinal fascicius, uncinate fasciculus) being sparsely af-
fected in age-related cerebral small vessel disease.
However, while this may partly account for the observed
maps of WMH progression, it does not fully explain the
more severe involvement that is apparent within the corti-
cospinal tract, that has also previously been observed in
Figure 4 Significant regions of negative correlation between grey matter rate maps and overall WMH rate. T-statistic shown at
P5 0.001 uncorrected and FWE P5 0.05.
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Table 3 Summary of MRI parameters, demographics and risk factors for participants who dropped out during the
study compared against those who continued
Final time point Time 1 Time 2
Outcome Withdrew Continued Withdrew Continued
n 18 81 10 71
Demographics and risk factors
Age at time point (years) 68.93 (12.10) 69.97 (10.01) 74.05 (11.41) 70.71 (9.25)
Female (n) 5 28 2 26
Male (n) 13 53 8 45
Hypertension (n) 17 75 9 66
Hypercholesterolaemia (n) 16 69 7 62
Current smoker (n) 4 17 2 15
Ex-smoker (n) 8 26 4 22
Diabetes (n) 0 19 2 17
Volume measurements
Mean grey matter (mm3) 655 534 (61 751) 656 034 (66 053) 644 884 (64 900) 652 157 (66 547)
Mean white matter (mm3) 307 950 (64 825) 327 490 (58 089) 312 384 (45 257) 330 778 (56 376)
Mean total cerebral volume (mm3) 1 022 801 (104 170) 1 025 065 (103 547) 1 017 806 (69 871) 1 020 077 (105 874)
Median WMH (mm3) 47 135 (35 834) 35 370 (29 271) 53 975 (32 848) 31 111 (25 314)
Median lacunar infarct (mm3) 120 (637) 279 (757) 332 (931) 294 (770)
Percentage change from baseline (%)
Mean grey matter 4.50 (2.21) 4.02 (2.15) 4.26 (3.10) 3.80 (1.67)
Mean white matter 3.00 (3.07) 2.44 (4.45) 6.23 (6.72) 1.5 (3.32)
Mean total cerebral volume 2.36 (1.41) 2.46 (1.23) 3.15 (1.16) 3.22 (6.20)
Median WMH 21.14 (37.77) + 13.34 (31.97) + 12.72 (434) + 16.21 (693)
Median lacunar infarct + 31.10 (35.19) + 19.61 (12.85) + 11.19 (32.97) + 13.95 (30.22)
Annualized fitted rates (mm3/year)
Mean grey matter 30 373 (15 488) 25 647 (13 692) 14 202 (10 222) 14 469 (13 851)
Mean white matter 9273 (9060) 7845 (12 973) 10 405 (12 355) 6406 (15 973)
Mean total cerebral volume 24 598 (12 234) 24 958 (12 234) 15 805 (5604) 15 522 (28 293)
Median WMH + 12 914 (15 317) + 5860 (9043) + 8892 (4127) + 4825 (5453)
Median lacune + 39 (133) + 29 (133) + 28 (84) + 26 (135)
Values in brackets are SD, P5 0.05, P5 0.005, P5 0.0005.
Figure 5 Significant regions of negative correlation between WMH rate maps and with overall grey matter rate. T-statistic
shown at P5 0.001 uncorrected and FWE P5 0.05.
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CADASIL (cerebral autosomal-dominant arteriopathy with
subcortical infarcts and leukoencephalopathy; Craggs et al.,
2014). Further work is required to better explain these ob-
servations, both to clarify and map white matter metabol-
ism in vivo and to quantify regional axonal and myelin
densities in humans.
Rate of grey matter atrophy and
functional implications
Previous work demonstrated cortical thinning associated
with WMH volume (Lambert et al., 2015; Tuladhar et
al., 2015), and proposed a phenotypic pattern of cortical
atrophy that characterizes increasing WMH severity inde-
pendently of age, namely parieto-occipital, posterio-super-
ior temporal, cingulate, middle frontal, orbitofrontal
cortical thinning, with the previously observed sparing of
the medial temporal lobe and hippocampus (Du et al.,
2005). This study builds upon those cross-sectional obser-
vations by demonstrating an increasing rate of atrophy in
these regions as the rate of WMH growth increases, while
controlling for age and lacunar infarct (Appelman et al.,
2009), and that it is this regional grey matter decline that
contributes most to global brain atrophy measures rather
than volumetric white matter loss. The observation that the
majority of volume loss occurs in the cortex, quite remote
from the regions of WMH growth, means that mis-segmen-
tation of the T1 images due to WMH is unlikely to account
for this result. Furthermore, this study has taken great
lengths to minimize any issues relating to tissue mis-seg-
mentation. Functionally these cortical regions overlap, par-
ticularly in the frontal areas, with previously described grey
matter changes in small vessel disease associated with gait
(de Laat et al., 2012) and disturbances in executive func-
tion and processing speed (Gunning-Dixon and Raz, 2003;
Raji et al., 2012). This pattern of atrophy, coupled with the
strong association with WMH load and regional progres-
sion, would be consistent with a white matter disconnec-
tion phenomenon and is concordant with the previously
described changes in cortical networks in small vessel dis-
ease (Lawrence et al., 2014) and in CADASIL (Duering et
al., 2011). These observations suggest that therapies to
slow or halt end-arteriole damage and therefore reduce
WMH progression would slow the rate of cortical atrophy
due to small vessel disease, preventing the secondary func-
tional morbidity that has been well described with these
changes (Nitkunan et al., 2011; de Laat et al., 2012;
Jokinen et al., 2012).
Limitations
There are several limitations with this current work. First,
while every effort was made to develop a fully automated,
non-biased approach, the segmentations still required a
degree of manual correction. However, better quality iso-
tropic data using higher ﬁeld strengths and image reso-
lutions resulting in improved tissue contrast would be
required to reﬁne this approach further to allow a fully
automated, non-biased pipeline that would enable increas-
ingly accurate quantiﬁcation of disease. Additionally, the
lacune correction method used will only provide an ap-
proximation of the expected tissue type. This could be po-
tentially improved in the future by using a more elaborate
model, for example using large datasets of normal brain
MRI scans to train a classiﬁer to estimate a missing voxel
information (due to an ischaemic lesion) based upon sur-
rounding neighbourhood information.
As described in the ‘Introduction’ section, small vessel
disease ranges from mild asymptomatic disease to severe
disease with dementia. To allow study of a more homogen-
ous group we applied strict inclusion criteria of a symp-
tomatic lacunar infarct as well as conﬂuent leukoaraiosis.
Nevertheless, there was some heterogeneity within our
population as suggested by the extreme outliers, whose
rate of disease progression was an order of magnitude
higher than the rest of the group. Additionally, the dropout
cohort had more rapidly progressive small vessel disease, as
indicated by the volumes and rates of progression of WMH
compared to those who continued in the study (Table 3). A
post hoc subgroup analysis of the MRI parameters accord-
ing to participant endpoint (Supplementary Table 1) indi-
cates that those who converted to dementia, died, or had a
major stroke had higher overall rates of WMH lesion load
and annualized progression compared to those who volun-
tarily withdrew from the study. However, there is not suf-
ﬁcient data for formal analysis and further work with
larger numbers of subjects is required to explore these re-
lationships. While the overall number of subjects may be a
limitation in this regard, in relation to all previous longitu-
dinal studies examining WMH progression using MRI
(Supplementary Table 2), our work is comparable [all pre-
vious studies: median number of subjects = 119 (range 12–
1919), average delay = 3.66 years, average number of time
points = 2], and sufﬁcient to detect widespread, statistically
signiﬁcant anatomical changes associated with WMH pro-
gression which was the primary objective of this work.
Additionally, it should also be acknowledged that the
cohort of ‘symptomatic small vessel disease’ characterized
by this work may not necessarily be representative of same
pathology observed in sporadic ‘age-related small vessel
disease’, and the results should be interpreted accordingly.
Although our work suggest an important role for WMH
in the progression of brain atrophy it cannot completely
exclude additional contributions from other processes,
such as cortical microinfarcts or denervation secondary to
subcortical lacunes. While we have attempted to control for
overall lacunar damage by using the total volume of tissue
damage as a covariate in our analysis, this fails to account
for local downstream lacune effects (Duering et al., 2015).
However, for lacunar damage to signiﬁcantly change the
focal rates of atrophy and survive family wise error correc-
tion in a voxel-wise analysis, new regions of lacunar
damage would need to either overlap or cluster closely
over the majority of subjects. Instead we found that the
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spatial distribution of new lacune damage is widely spread,
with preponderance for the striatum but low levels of over-
lap across subjects (Supplementary Fig. 3). Furthermore, by
sampling the volume of grey matter loss within signiﬁcant
regions (Fig. 4), we estimate that the amount of atrophy
observed in our study is 20 times larger than that re-
ported by Duering et al. (2015). In summary, it is unlikely
that lacunar damage contributes signiﬁcantly to the re-
gional variation observed, both in rates of atrophy and
WMH growth.
Additionally, a lack of a control group means that
normal ageing effects on this process cannot be entirely
excluded. However, the multiple regression model included
age as a confounding covariate, therefore is unlikely to
contribute signiﬁcantly to the associations between WMH
and grey matter rates. Additionally, we found no signiﬁcant
correlations between grey matter rates, WMH rates and
age, and also the overall WMH volume did not correlate
with age or total cerebral volume at baseline in our cohort.
This means multicollinearity problems (Kraha et al., 2011;
Lambert et al., 2015) due to relationships between age and
WMH are unlikely to be a signiﬁcant issue in this work.
While we suggest the pattern of grey matter atrophy
described may represent a so-called ‘phenotypic pattern’
for small vessel disease, this is by no means deﬁnitive as
it is based on qualitative comparisons between earlier re-
sults reported by ourselves (Lambert et al., 2015) and
Tuladhar et al. (2015), being compared against previous
published ﬁndings in ageing (Draganski et al., 2011;
Tamnes et al., 2013), dementia (Whitwell et al., 2007;
Ossenkoppele et al., 2015) and parkinsonian syndromes
(Price et al., 2004; Tessa et al., 2014). Further work
would be required to directly compare these and ascertain
the contributions of each to spatial patterns of cortical at-
rophy, both occurring in isolation and in combination with
one another.
Finally, while we acknowledge that this current work not
report any neuropsychological correlates, each subject is
still being followed-up clinically with an annual neuropsy-
chological battery (Lawrence et al., 2013). Over the 3-year
period reported here, there was no marked decline in the
measured cognitive parameters and therefore we lacked the
power to look for neuroanatomical correlates. However,
we are following cases up for 5 years. In subjects who
have reached this time point there now appears to be a
signiﬁcant decline in cognition, and future work will ana-
lyse this formally once the follow-up period has been fully
completed.
Conclusion
In conclusion this work further deﬁnes the pattern of
WMH growth in symptomatic cerebral small vessel disease,
and demonstrated that the rate of WMH growth is linked
to the underlying white matter anatomy of the long asso-
ciation fasciculi. Additionally, we have shown that the rate
of WMH growth is strongly correlated with regional grey
matter atrophy, which in turn causes the secondary reduc-
tions in global brain volume, that have been previously
observed to be related to other cognitive and functional
outcomes. It suggests an important role of WMH progres-
sion in the genesis of brain atrophy and implies that thera-
pies aimed at reducing WMH progression via end-arteriole
damage may also protect against secondary brain atrophy
and consequent functional morbidity. The magnetic reson-
ance-based morphometric techniques developed here pro-
vide 3D, sensitive, quantitative metrics of small vessel
disease severity and progression that can be used in the
future for patient stratiﬁcation and objectively monitoring
therapeutic clinical trials in this highly prevalent disease.
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